Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Carlsten
Checkpoint Inhibition of KIR2D With the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients With Myeloma
Clinical Cancer Research
Cancer Research
Oncology
A Phase II Trial of Pan-Kir2d Blockade With IPH2101 in Smoldering Multiple Myeloma
Haematologica
Hematology
Related publications
Immune Checkpoint Inhibition in Patients With Brain Metastases
Annals of Translational Medicine
Medicine
213Bi Radioimmunotherapy With an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Inhibition of Increased Circulating TFH Cell by Anti-Cd20 Monoclonal Antibody in Patients With Type 1 Diabetes
PLoS ONE
Multidisciplinary
Identification of Human Plasma Cells With a Lamprey Monoclonal Antibody
JCI insight
Medicine
Efficient Inhibition of P-Glycoprotein-Mediated Multidrug Resistance With a Monoclonal Antibody.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Phase 1 Study of Lirilumab (Antibody Against Killer Immunoglobulin-Like Receptor Antibody KIR2D; IPH2102) in Patients With Solid Tumors and Hematologic Malignancies
Oncotarget
Oncology
Inhibition of QPCTL Induces Myeloid Immune Checkpoint Blockade
Cancer Discovery
Oncology
The Mechanism of Action of the Anti-Cd38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
